Registered number
10329324
Leo Medica Europe Limited
Filleted Accounts
31 December 2024
Leo Medica Europe Limited
Registered number: 10329324
Balance Sheet
as at 31 December 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 513 -
Current assets
Stocks 17,169 -
Debtors 4 9,118 12,540
Cash at bank and in hand 27,333 75,758
53,620 88,298
Creditors: amounts falling due within one year 5 (44,302) (79,609)
Net current assets 9,318 8,689
Total assets less current liabilities 9,831 8,689
Creditors: amounts falling due after more than one year 6 (3,937) (8,000)
Net assets 5,894 689
Capital and reserves
Called up share capital 200 200
Profit and loss account 5,694 489
Shareholders' funds 5,894 689
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Amol Balasaheb Solanke
Director
Approved by the board on 29 May 2025
Leo Medica Europe Limited
Notes to the Accounts
for the year ended 31 December 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 2
Leo Medica Europe Limited 10329324 false 2024-01-01 2024-12-31 2024-12-31 VT Final Accounts April 2024 Amol Balasaheb Solanke No description of principal activity 10329324 2023-01-01 2023-12-31 10329324 core:WithinOneYear 2023-12-31 10329324 core:AfterOneYear 2023-12-31 10329324 core:ShareCapital 2023-12-31 10329324 core:RetainedEarningsAccumulatedLosses 2023-12-31 10329324 2024-01-01 2024-12-31 10329324 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10329324 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 10329324 bus:Director40 2024-01-01 2024-12-31 10329324 1 2024-01-01 2024-12-31 10329324 2 2024-01-01 2024-12-31 10329324 bus:FRS102 2024-01-01 2024-12-31 10329324 bus:FilletedAccounts 2024-01-01 2024-12-31 10329324 2024-12-31 10329324 core:WithinOneYear 2024-12-31 10329324 core:AfterOneYear 2024-12-31 10329324 core:ShareCapital 2024-12-31 10329324 core:RetainedEarningsAccumulatedLosses 2024-12-31 10329324 2023-12-31 iso4217:GBP xbrli:pure